Skip to main content
JAMA Network logoLink to JAMA Network
. 2021 Dec 14;326(22):2333. doi: 10.1001/jama.2021.21529

Incorrect Wording in 2 Places

PMCID: PMC8672227  PMID: 34905047

In the Original Investigation titled “Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial,”1 published in the November 9, 2021, issue of JAMA, the word “reduce” should have been “increase” in 2 places. In the “Meaning” section of the Key Points and in the “Conclusion” section of the Visual Abstract, the sentence should have been “Compared with 6 mg of dexamethasone, 12 mg of dexamethasone did not statistically significantly increase the number of days alive without life support at 28 days.” This article was corrected online.

References

  • 1.Munch MW, Myatra SN, Vijayaraghavan BKT, et al. ; COVID STEROID 2 Trial Group . Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial. JAMA. 2021;326(18):1807-1817. doi: 10.1001/jama.2021.18295 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA are provided here courtesy of American Medical Association

RESOURCES